论文部分内容阅读
目的:研究莫沙必利在治疗功能性消化不良上的临床疗效。方法:选取我院70例功能性消化不良患者,将其随机分成对照组和观察组,分别采用吗丁啉和莫沙必利治疗,对比两组患者治疗后的疗效、不良反应和临床症状评分。结果:观察组的临床疗效优于对照组,P<0.05,具有统计学意义。两组患者的不良反应发生率相差不大,不具有显著差异。观察组的临床症状评分优于对照组,且P<0.05,具有统计学意义。结论:在功能性消化不良的治疗上,莫沙比利比吗丁啉的效果更好,且安全性更高,具有重大临床应用价值,值得在临床上推广使用。
Objective: To study the clinical efficacy of mosapride in the treatment of functional dyspepsia. Methods: Seventy patients with functional dyspepsia in our hospital were randomly divided into control group and observation group. Patients in both groups were treated with domperidone and mosapride respectively. The curative effect, adverse reactions and clinical symptom scores were compared between the two groups . Results: The clinical efficacy of the observation group was better than that of the control group, P <0.05, with statistical significance. The incidence of adverse reactions in the two groups of patients was similar, with no significant difference. Clinical symptom score in the observation group was better than that in the control group, and P <0.05 was statistically significant. Conclusion: Mosapride is more effective and effective than dobutamine in the treatment of functional dyspepsia. It has great clinical value and is worth popularizing in clinic.